Oncology application announcements have continued to mount in the run up to the American Society for Clinical Oncology (ASCO) annual meeting in Chicago.
Priority review vouchers also earned the spotlight, as two companies – Amicus Therapeutics Inc.and Abeona Therapeutics Inc